share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thompson Matthew

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thompson Matthew

Vivos Therapeutics | 4：持股变动声明-董事 Thompson Matthew
美股sec公告 ·  06/28 20:57
Moomoo AI 已提取核心信息
In a recent transaction, Matthew Thompson, associated with Vivos Therapeutics, Inc. [VVOS], executed a stock transaction on June 20, 2024. The specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed. This event may be of interest to investors who follow Vivos Therapeutics, as insider transactions can provide insights into the company's financial health and future prospects.
In a recent transaction, Matthew Thompson, associated with Vivos Therapeutics, Inc. [VVOS], executed a stock transaction on June 20, 2024. The specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed. This event may be of interest to investors who follow Vivos Therapeutics, as insider transactions can provide insights into the company's financial health and future prospects.
在最近的一项交易中，与vivos therapeutics有关的马修·汤普森（Matthew Thompson）于2024年6月20日进行了股票交易。具体交易细节，如涉及的股票数量、交易价格和结果的参股金融等未披露。此事件可能受到关注vivos therapeutics的投资者的关注，因为内部交易可为公司的财务健康和未来前景提供有见地的洞察。
在最近的一项交易中，与vivos therapeutics有关的马修·汤普森（Matthew Thompson）于2024年6月20日进行了股票交易。具体交易细节，如涉及的股票数量、交易价格和结果的参股金融等未披露。此事件可能受到关注vivos therapeutics的投资者的关注，因为内部交易可为公司的财务健康和未来前景提供有见地的洞察。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息